Architecture, engineering and facilities design supports more resilient installations for U.S. Department of Defense Jacobs (NYSE: J) was selected by the Japan District of the U.S. Army Corps of Engineers (USACE) to deliver architecture and engineering services through a multiple award task order contract to support the U.S. Department of Defense (DoD). Under this contract, […]
This year, Cadence, a globally recognized, women-owned travel company, celebrates an extraordinary milestone-their 30th anniversary. From ambitiousbeginnings, Cadence has grown into a respected powerhouse, offering corporate travel services, meetings and incentive programs, and serving as a host agency to an elite network of over 180 independent luxury travel advisors. https://mma.prnewswire.com/media/2602980/Cadence_Travel_wendy_burk_ceo_cadence_travel_la_jolla.jpg “We lead with care, are
Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built in China through the CNNC-Accuray joint venture. Shandong Cancer Hospital and Institute was the first hospital in China to receive
(TSX-V:TTS), TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) — Tintina Mines Limited (“Tintina” or the “Company”) (TSXV: TTS) is pleased to announce that the Company has filed an initial Mineral Resource Estimate (“MRE”) titled “NI 43-101 Independent Technical Report, Mineral Resource Estimate for the Domeyko Sulfuros Project, Atacama Region, Chile”. Highlights Inferred resources: 320 Mt in
CrossFAST performance exceeded expectations in ten complex high-risk coronary interventions Vantis Vascular, Inc., a pioneering medical technology company founded by physicians with a passion to revolutionize vascular interventions, today announced the first commercial use of its CrossFAST Integrated Microcatheter Advanced Delivery System in a series of ten successful complex high-risk coronary interventional procedures (CHiP). The
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=124578&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK CITY, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=124577&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Five9, Inc. (NASDAQ:FIVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/five9-inc-lawsuit-submission-form?prid=124573&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=124572&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Customers Bancorp, Inc. (NYSE:CUBI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/customers-bancorp-inc-lawsuit-submission-form?prid=124569&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or